Built for Business Development, Search and Evaluation, and M&A

Validate the Asset
Before the Room Asks You To

The diligence room challenges every assumption, and your thesis is only as strong as the evidence beneath it. That evidence is scattered across sources that do not agree. Optimistic sponsor estimates fall apart the moment they meet the comparator set. Kognitic gives you a comparative view that holds up under scrutiny, before the meeting rather than after weeks of reconciliation.

Built for VP, Senior Director, Director, and Executive Director of Business Development and Licensing, Search and Evaluation, New Product Planning, Strategic Transactions, and Corporate Development.

Live Asset Scorecard · Target asset · ADC HER2 low, 2L
core.kognitic.com/asset-eval

Differentiation

74%

vs comparator median

Defensible

Comparator set

3+2

3 approved, 2 late-stage

Density Moderate

Window vs next entrant

Time to close

Late-stage entrant closing gap

Narrowing

Diligence status

Ready

Normalized, sourced, defensible

Holds up

Illustrative view. Programs, indications, and figures are representative.

The Legacy Playbook

Every Assumption Gets Challenged.
Have the Evidence Ready.

The deal memo has to support the thesis from every angle, and internal forecasts built on optimistic sponsor estimates fall apart on close inspection. The room will find the weak assumption. The question is whether you find it first.

Sponsor deck Data room export Analyst model Comparator PDFs Optimistic NPV KOL call notes Competing pipeline Registry pull Endpoint mismatch Old benchmark Diligence checklist

Sponsor estimates look optimistic the moment they meet the comparator set

The differentiation case has to survive scrutiny, not just internal review.

Competitive density around the target is not clear until the deal is already deep

The window narrows while the picture is still being assembled.

Is the window still open, or has the asset already been overtaken?

A faster entrant changes the thesis. Kognitic surfaces it before you sign.

Why BD and Search and Evaluation Teams Choose Kognitic

A Deal Rationale That Holds Under Scrutiny

The highest deal-stakes per decision in the building. Kognitic gives you a comparative view built to survive the diligence room.

Asset Differentiation, Made Defensible

Best-in-class versus me-too across endpoints, biomarker segments, lines of therapy, and treatment settings. Stress-test the claim before the room does.

Is the Window Still Open?

Competitive density and white space around the target. Kognitic surfaces whether the asset still has room, or whether a faster entrant has closed it.

Speed to a View You Can Stand Behind

The strategic view arrives before the meeting, not after three weeks of analyst reconciliation. Walk in with evidence that holds up under diligence.

The Decision View

The Asset, Stress-Tested
Before the Room

One comparative view across the comparator set, normalized to the endpoints that get challenged.

The read you walk into diligence with.

Asset Evaluation View Diligence-ready
core.kognitic.com/asset-eval/decision-view

Target asset

ADC · HER2 low

2L Above comparator median 74% · Strong Holds up

Approved comparator

SOC combination

2L Established baseline 50% · Moderate Reference

Late-stage entrant

Competing modality

2L Optimistic sponsor claim 44% · Unproven Stress-test

Differentiation

Target holds a defensible position above the comparator median across the endpoints most likely to be challenged.

Normalized · cross-study

Is the Window Open?

A late-stage entrant is closing the gap. The differentiation case is strongest if the deal moves this cycle.

Signal · window narrowing

Rationale That Holds

The comparative view arrives before diligence, not after three weeks of analyst reconciliation.

Defensible · sourced

Illustrative view. Assets, comparators, and figures are representative.

The Legacy Playbook

The Engine Behind
the Evaluation

Asset evaluation draws on Core for the competitive picture and Outcomes for the comparative evidence that holds up in diligence.

Core

Clinical Trial Intelligence

Competitive density, timelines, and the window around the target. The live picture of who else is moving.

Explore Core →
Outcomes

Clinical Evidence Intelligence

Cross-study benchmarking normalized across endpoints and settings. Differentiation made defensible.

Explore Outcomes →
API

Data Access Layer

The same normalized evidence, machine-ready for the valuation models your team builds on.

Explore the API →

The Kognitic Difference

Optimistic on One Side.
Incomplete on the Other.
Neither Survives Diligence.

Sponsor Materials

Built to Persuade

Best-case framing and endpoints chosen to flatter. The assumptions that matter are the ones left out.

Legacy Databases

Reference Without Rationale

Broad coverage, no comparative view. The differentiation work still lands on your analysts, under deadline.

Then there's Kognitic

A View That Holds Up

Normalized cross-study benchmarking. Differentiation across endpoints and settings. The rationale arrives before the room asks for it.

Kognitic portfolio decision-view dashboard

The Room Will Ask

Have the Answer
Before They Do

See how Kognitic stress-tests an asset against its comparator set into a diligence-ready view. Thirty minutes, on a target in your space.